CANTON, MA (PRWEB) January 06, 2014
The Association of Strategic Alliance Professionals (ASAP), the world’s leading professional association dedicated to the practice of alliance management, today announced that leading contract research organization (CRO) Covance Inc. has upgraded to ASAP Global Member status.
An ASAP Corporate Member for several years, Covance’s elevation to Global Member status reflects the company’s deep commitment to close collaborations with its customers, which range from large, global pharmaceutical companies and well-established biotechs to smaller, emerging biopharmaceutical organizations. Each year pharmaceutical companies outsource more and more critical nonclinical and clinical development work. The increasing complexity of these assignments requires more than deep functional expertise, necessitating engagements that are far more intimate and intertwined than traditional transactional relationships.
“Today clients seek partners who offer anticipatory thinking, deliver insightful solutions, and operate as a seamless extension of their own team,” said John Watson, president of strategic partnering and chief commercial officer for Covance. “Our goal is to deliver this type of consultative and collaborative experience to every client, whether large pharma or emerging biotech, with every interaction. ASAP’s extensive resources will further enhance our existing alliance management capabilities and help us establish and expand enduring relationships with all our clients.”
Covance is a leading full-service drug development company, with capabilities uniquely spanning both early- and late-stage development. In addition to helping develop 46 of the 50 top-selling drugs, and 82 percent of all FDA-approved drugs in 2012, the organization has also pioneered the design of landmark alliances between CROs and the pharmaceutical industry.
The company is utilizing ASAP in a number of ways. It is significantly increasing the number of professionals certified in current alliance management practices and methodologies, sending personnel to leading global ASAP events such as the ASAP BioPharma Conference and ASAP Global Alliance Summit and providing representation on ASAP’s board to help chart the direction of the organization and the profession. In addition, as an ASAP Global Member Covance will have the opportunity to add executives from its partner organizations to its membership roster, thereby giving them access to the plethora of ASAP benefits, including:
“Across the biopharmaceutical industry, pipelines are becoming increasingly dependent on partnerships, particularly in the clinical phases of the drug development cycle,” said Michael Leonetti, president and CEO of ASAP. “Companies like Covance turn to ASAP to provide their personnel access to the tools, training and networking opportunities with the profession’s most respected thought leaders that will ensure their collaborations achieve the organization’s most pressing objectives. We are proud to play an important role in helping Covance maintain its successful hand-in-hand customer relationships.”
The Association of Strategic Alliance Professionals (ASAP) is the only professional association dedicated to elevating and promoting the profession of alliance management. Founded in 1998, the organization provides professional development, networking and resources for cultivating the skills and toolsets needed to manage successful business partnerships. Active global members include AbbVie, AstraZeneca, CA Technologies, Capgemini, Cisco, Citrix, Covance, Dell, Eli Lilly and Company, IBM, the Janssen Pharmaceutical Companies, Microsoft, Motorola, Novartis, Sanofi, SAS, Schneider Electric, Verizon, VMware, The Warren Company and Xerox. A complete list of global and corporate members is available at http://www.strategic-alliances.org. For more information about Individual, Corporate or Global membership, contact Lori Gold at +1-781-562-1630, ext. 203.
# # #